Phil Garner

Co-Founder & CEO, Becaris Publishing (@_Becaris). Focus on all things RWE and HEOR. Views my own.

[The Evidence Base @TheEviBase]

NEW #WEBINAR ALERT

Uncovering disparities in access to popular treatments: insights from linked EHR and SDOH data - June 26, 1:00pm ET

https://t.co/trOJPCX4hp

Experts from @truveta explore linked #EHR and #SDOH data for #diabetes, #Alzheimersdisease and #heartdisease.

[Phil Garner @grnr25]

EU HTA Joint Clinical Assessment: are patients with rare disease going to lose out? https://t.co/rLgzf6AZNc

[Phil Garner @grnr25]

#ISPORAnnual

[The Evidence Base @TheEviBase]

_ @ISPORorg 2024: Navigating the conference program https://t.co/NeAmwyhffA

[The Evidence Base @TheEviBase]

With the #olympics2024 in July, the subject of sports #doping and drug cheats will no doubt become a hot topic again😞.

With that, the PCSIG is proud to announce a new #webinar, moderated by Neil Spooner.

Register: https://t.co/OqsjbIdR0b

[The Evidence Base @TheEviBase]

Webinar from @TheEviBase. Register: https://t.co/7vce3PbUZR.

[The Evidence Base @TheEviBase]

WEBINAR: Enabling timely comparative effectiveness research: head-to-head analysis of GLP-1s for weight loss – January 25, 2024 In partnership with @truveta https://t.co/92fWMijWUS

[The Evidence Base @TheEviBase]

We're delighted to announce our 2024 Editorial Calendar, covering key topics in our field.

https://t.co/iOV6GGzYCg

Topics covered include #marketaccess, #healthdata, #HTA, #AI, #healthequity, #orphandrugs, #rarediseases, #patientengagement and #digitalhealth, #rwe.

[The Evidence Base @TheEviBase]

Register for this upcoming webinar on @TheEviBase Base, in association with the PCSIG.

https://t.co/i6qd7Rp2VH

Thank you to our sponsors, Alturas Analytics, Capitainer, @genentech, @TassoInc, Veloxity Labs and @yourbio_health.

[Phil Garner @grnr25]

Brazil’s @anvisa_oficial releases new real-world evidence guidelines https://t.co/dfTtSa9nun

[The Evidence Base @TheEviBase]

Join @aetioninc and @TheEviBase for this new webinar, SURFing the Waters of Real-World Evidence!

Register here: https://t.co/J0gQIuUZig

Join us, November 8 at 11am EST.

#realworldevidence #rwe #realworlddata #FDA

[Phil Garner @grnr25]

COTA launches new real-world data platform to accelerate cancer research and advance generative AI models in oncology https://t.co/iCFGEmVgzN

[The Evidence Base @TheEviBase]

Read highlights from the latest instalment of Sreeram Ramagopalan’s (@LCP_Actuaries) industry news round-up, which discusses some of the latest developments regarding real-world evidence in the context of health technology assessment >>> https://t.co/787o2Jqn0A

#RWE #HTA

[Phil Garner @grnr25]

@Om1Inc launches curated real-world dataset for Parkinson’s disease to further neuroscience real-world evidence https://t.co/n6f8y7cu1q

[Phil Garner @grnr25]

@US_FDA final guidance for industry on use of real-world data and real-world evidence to support regulatory decision-making https://t.co/TWbQjxsifY

[The Evidence Base @TheEviBase]

WEBINAR: IN-HOME AKI Monitoring in Cancer Patients: From Concept to Clinical Evaluation – September 27th 2023 https://t.co/NPGiD2Kzux

[Journal of Comparative Effectiveness Research @Journal_CER]

New study assesses whether routine #PRO monitoring alone has an impact on real-world overall survival and hospitalizations among individuals diagnosed with lung, breast, or colorectal #cancer >>> https://t.co/LxmEE6wrhv

[The Evidence Base @TheEviBase]

Our weekly round-up has now been published and includes the @OHENews report on real-world evidence in reimbursement decision making and a new label expansion by the @US_FDA marking a milestone in the regulatory use of RWE for medical devices.

Read here >> https://t.co/5PypyqmzXM

[The Evidence Base @TheEviBase]

Johnson & Johnson and Astellas add to the growing number of lawsuits filed against the US Inflation Reduction Act’s drug price negotiation provisions https://t.co/0934Sl68Io

[The Evidence Base @TheEviBase]

Read highlights from the latest instalment of Sreeram Ramagopalan’s industry news round-up, discussing some of the latest developments regarding #RWE in the context of #HTA and is published bi-monthly in our partner journal @Journal_CER >>> https://t.co/Ku0aKiglDW

[Journal of Comparative Effectiveness Research @Journal_CER]

Study demonstrates an algorithm for selecting statistical models for network meta-analyses where the treatment effect varies over time.

#CER #HEOR #MetaAnalysis

>>> https://t.co/UV6rxghFx8